Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2022 | Targeted therapies in metastatic urothelial carcinoma

Daniel Petrylak, MD, Yale Cancer Center, New Haven, CT, gives an overview of current research into targeted therapies in metastatic urothelial carcinoma. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.